Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-390507

Co-Chief Executive Officer sold 30,464 shares at an average $32.19 ($980,504)

From the SEC's structured data for this filing

Trades in this filing

Cohen Joshua B · Co-Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-10 Sale : show line 1 in the form −29,545 $32.16 $950,040 3,614,042 D
2026-09-10 Sale : show line 2 in the form −919 $33.15 $30,464 3,613,123 D
Open-market sales · 30,464 sh · avg $32.19 · $980,504
Loading xslF345X06/ownership.xml…